Epidermolysis Bullosa: Pediatric Perspectives.
Hon KL, Chu S, Leung AKC.
Curr Pediatr Rev. 2022;18(3):182-190. doi: 10.2174/1573396317666210525161252.
Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes.
Varki R, Sadowski S, Uitto J, Pfendner E.
J Med Genet. 2007 Mar;44(3):181-92. doi: 10.1136/jmg.2006.045302. Epub 2006 Sep 13.
Identical glycine substitution mutations in type VII collagen may underlie both dominant and recessive forms of dystrophic epidermolysis bullosa.
Almaani N, Liu L, Dopping-Hepenstal PJ, Lai-Cheong JE, Wong A, Nanda A, Moss C, Martinéz AE, Mellerio JE, McGrath JA.
Acta Derm Venereol. 2011 May;91(3):262-6. doi: 10.2340/00015555-1053.
Dystrophic Epidermolysis Bullosa.
Yadav RS, Jayswal A, Shrestha S, Gupta SK, Paudel U.
JNMA J Nepal Med Assoc. 2018 Sep-Oct;56(213):879-882. doi: 10.31729/jnma.3791.
Recessive Dystrophic Epidermolysis Bullosa: Advances in the Laboratory Leading to New Therapies.
Woodley DT, Chen M.
J Invest Dermatol. 2015 Jul;135(7):1705-1707. doi: 10.1038/jid.2015.149.
Unravelling drivers of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
Santucci C, Alexandru M, Chen X, Mellerio JE, Karagiannis SN, Jacków-Malinowska J.
Hum Immunol. 2024 May;85(3):110805. doi: 10.1016/j.humimm.2024.110805. Epub 2024 May 4.
Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosa.
Vanden Oever M, Twaroski K, Osborn MJ, Wagner JE, Tolar J.
Pediatr Res. 2018 Jan;83(1-2):318-324. doi: 10.1038/pr.2017.244. Epub 2017 Nov 1.
The potential of gene therapy for recessive dystrophic epidermolysis bullosa.
Subramaniam KS, Antoniou MN, McGrath JA, Lwin SM.
Br J Dermatol. 2022 Apr;186(4):609-619. doi: 10.1111/bjd.20910. Epub 2022 Apr 1.
Inpatient management of children with recessive dystrophic epidermolysis bullosa: A review.
Li AW, Prindaville B, Bateman ST, Gibson TE, Wiss K.
Pediatr Dermatol. 2017 Nov;34(6):647-655. doi: 10.1111/pde.13276. Epub 2017 Sep 25.
Systemic treatment of recessive dystrophic epidermolysis bullosa with mesenchymal stromal cells: a scoping review of the literature and conclusions for future clinical research.
Niebergall-Roth E, Dieter K, Frank MH, Kluth MA.
J Dermatolog Treat. 2024 Dec;35(1):2419931. doi: 10.1080/09546634.2024.2419931. Epub 2024 Nov 17.
